Bregua Corp 13D and 13G filings for Janux Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-04 4:05 pm Sale |
2024-09-30 | 13G | Janux Therapeutics, Inc. JANX |
Bregua Corp | 2,999,990 5.800% |
-830,267 (-21.68%) |
Filing |
| 2024-02-01 4:15 pm Purchase |
2023-12-31 | 13G | Janux Therapeutics, Inc. JANX |
Bregua Corp | 3,830,257 8.300% |
81,007 (+2.16%) |
Filing |
| 2021-06-25 06:08 am Purchase |
2021-06-15 | 13G | Janux Therapeutics, Inc. JANX |
Bregua Corp | 3,749,250 9.000% |
3,749,250 (New Position) |
Filing |